Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

March 2018

Feature

Research Reports
Community Oncologists` Perception and Acceptance of Biosimilars in Oncology
09/13/2018
Chadi Nabhan, MD, MBA, FACP
Yolaine Jeune-Smith, PhD
Amy Valley, PharmD
Bruce A Feinberg, DO
Abstract: Biosimilars are hypothesized to contribute to lowering health care costs by entering the market at a discounted price compared with their reference biologics. Until recently, only filgrastim biosimilars...
Abstract: Biosimilars are hypothesized to contribute to lowering health care costs by entering the market at a discounted price compared with their reference biologics. Until recently, only filgrastim biosimilars...
...
09/13/2018
Journal of Clinical Pathways

Column

PATIENT PERSPECTIVE
The Time Has Come to Involve Patients in Clinical Pathways
03/15/2018
Alan Balch, PhD—Column Editor
Patients are not often given a voice in the development and implementation of clinical pathways, the main focus of which have been to provide treatment options and guidance primarily based on clinical medical...
Patients are not often given a voice in the development and implementation of clinical pathways, the main focus of which have been to provide treatment options and guidance primarily based on clinical medical...
...
03/15/2018
Journal of Clinical Pathways
Pharma Insights
What Changes When Medicine Goes Digital?
03/15/2018
Amanda Lever, BSc
Auralyn MacKenzie, BSc
Larry Blandford, PharmD—Column Editor
Health care has become increasingly digitalized, but until now drugs have escaped digitalization. Advancements in digital technologies are changing how we think about disease management and even disease treatment....
Health care has become increasingly digitalized, but until now drugs have escaped digitalization. Advancements in digital technologies are changing how we think about disease management and even disease treatment....
Health...
03/15/2018
Journal of Clinical Pathways
Clinical Pathways GPS
Targeting the Quadruple Aim Through Clinical Pathways
03/15/2018
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
All health care professionals recognize the Triple Aim, which is focused on outcomes, costs, and patient experiences. However, a fourth aim was added, which focuses on an essential, yet often forgotten, contribution...
All health care professionals recognize the Triple Aim, which is focused on outcomes, costs, and patient experiences. However, a fourth aim was added, which focuses on an essential, yet often forgotten, contribution...
All...
03/15/2018
Journal of Clinical Pathways
Editor's Page
Preserving Patient and Provider Voice in Clinical Pathway Development and Use
03/15/2018
Winston Wong, PharmD, Editor-in-Chief
In our increasingly digital world, providers’ and patients’ voices and individual needs must be prioritized. When it comes to treating others or being treated for incredibly complex illnesses, the health and...
In our increasingly digital world, providers’ and patients’ voices and individual needs must be prioritized. When it comes to treating others or being treated for incredibly complex illnesses, the health and...
In our...
03/15/2018
Journal of Clinical Pathways
Department
A Heart Failure Clinical Pathway to Reduce Hospital Readmissions
03/15/2018
JCP Editors
Heart failure (HF) is the primary diagnosis in over 1 million hospitalizations annually,1 and patients who are hospitalized for HF are at high risk for all-cause hospital readmission, with a 1-month readmission rate...
Heart failure (HF) is the primary diagnosis in over 1 million hospitalizations annually,1 and patients who are hospitalized for HF are at high risk for all-cause hospital readmission, with a 1-month readmission rate...
Heart...
03/15/2018
Journal of Clinical Pathways

News

Conference Coverage
American Society of Clinical Oncology Cancer Survivorship Symposium
03/15/2018
JCP Editors
The American Society of Clinical Oncology (ASCO) featured its Cancer Survivorship Symposium in Orlando, Florida from February 16-17, 2018. The meeting provided information about survivorship issues that both...
The American Society of Clinical Oncology (ASCO) featured its Cancer Survivorship Symposium in Orlando, Florida from February 16-17, 2018. The meeting provided information about survivorship issues that both...
The...
03/15/2018
Journal of Clinical Pathways
Conference Coverage
American Society of Clinical Oncology Genitourinary Cancers Symposium
03/15/2018
JCP Editors
The 2018 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium provides a forum for physicians and other members of the oncology care and research community who diagnose, treat, and...
The 2018 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium provides a forum for physicians and other members of the oncology care and research community who diagnose, treat, and...
The...
03/15/2018
Journal of Clinical Pathways

Department

Research in Review
Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine
03/15/2018
JCP Editors
ASCO Releases Review of Prominent Commercial Clinical Pathway Vendors The American Society of Clinical Oncology Task Force assessed 6 national pathway vendors to compare their products against the ASCO Criteria for...
ASCO Releases Review of Prominent Commercial Clinical Pathway Vendors The American Society of Clinical Oncology Task Force assessed 6 national pathway vendors to compare their products against the ASCO Criteria for...
ASCO...
03/15/2018
Journal of Clinical Pathways
Erratum
Erratum: Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs
03/15/2018
Ladan Golestaneh, MD, MS
 Paula J Alvarez, RPh, MPH, MBA
 Nancy L Reaven, MA
 Susan E Funk, MBA, FACHE
 Karen J McGaughey, PhD
 Alain Romero, PharmD, PhD
 Macaulay Onuigbo, MD, MSc, MBA
The article, “Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs,” appearing in the November 2017 issue of Journal of Clinical Pathways, was updated for minor editorial additions and...
The article, “Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs,” appearing in the November 2017 issue of Journal of Clinical Pathways, was updated for minor editorial additions and...
The...
03/15/2018
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Volume 4

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement